These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17596523)

  • 1. ACE inhibitor reduces growth factor receptor expression and signaling but also albuminuria through B2-kinin glomerular receptor activation in diabetic rats.
    Allard J; Buléon M; Cellier E; Renaud I; Pecher C; Praddaude F; Conti M; Tack I; Girolami JP
    Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1083-92. PubMed ID: 17596523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological blockade of B2-kinin receptor reduces renal protective effect of angiotensin-converting enzyme inhibition in db/db mice model.
    Buléon M; Allard J; Jaafar A; Praddaude F; Dickson Z; Ranera MT; Pecher C; Girolami JP; Tack I
    Am J Physiol Renal Physiol; 2008 May; 294(5):F1249-56. PubMed ID: 18367657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bradykinin inhibits high glucose- and growth factor-induced collagen synthesis in mesangial cells through the B2-kinin receptor.
    Blaes N; Pécher C; Mehrenberger M; Cellier E; Praddaude F; Chevalier J; Tack I; Couture R; Girolami JP
    Am J Physiol Renal Physiol; 2012 Jul; 303(2):F293-303. PubMed ID: 22573379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
    Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms through which bradykinin promotes glomerular injury in diabetes.
    Tan Y; Wang B; Keum JS; Jaffa AA
    Am J Physiol Renal Physiol; 2005 Mar; 288(3):F483-92. PubMed ID: 15692059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bradykinin reduces growth factor-induced glomerular ERK1/2 phosphorylation.
    Cellier E; Mage M; Duchêne J; Pécher C; Couture R; Bascands JL; Girolami JP
    Am J Physiol Renal Physiol; 2003 Feb; 284(2):F282-92. PubMed ID: 12388422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies.
    Allen TJ; Cao Z; Youssef S; Hulthen UL; Cooper ME
    Diabetes; 1997 Oct; 46(10):1612-8. PubMed ID: 9313758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combined neutral endopeptidase 24-11 and angiotensin-converting enzyme inhibition on femoral vascular conductance in streptozotocin-induced diabetic rats.
    Arbin V; Claperon N; Fournié-Zaluski MC; Roques BP; Peyroux J
    Br J Pharmacol; 2000 Jul; 130(6):1297-304. PubMed ID: 10903969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy.
    Thallas-Bonke V; Coughlan MT; Bach LA; Cooper ME; Forbes JM
    Am J Nephrol; 2010; 32(1):73-82. PubMed ID: 20551625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of skin wound healing in diabetic mice by kinin B2 receptor blockade.
    Desposito D; Chollet C; Taveau C; Descamps V; Alhenc-Gelas F; Roussel R; Bouby N; Waeckel L
    Clin Sci (Lond); 2016 Jan; 130(1):45-56. PubMed ID: 26443866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition.
    Liu CX; Hu Q; Wang Y; Zhang W; Ma ZY; Feng JB; Wang R; Wang XP; Dong B; Gao F; Zhang MX; Zhang Y
    Mol Med; 2011; 17(1-2):59-69. PubMed ID: 20844835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of the kinin B2 receptor pathway modulates the TGF-β/Smad signaling cascade to reduce renal fibrosis induced by albumin.
    Cárdenas A; Campos J; Ehrenfeld P; Mezzano S; Ruiz-Ortega M; Figueroa CD; Ardiles L
    Peptides; 2015 Nov; 73():7-19. PubMed ID: 26256678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual effect of angiotensin-converting enzyme inhibition on angiogenesis in type 1 diabetic mice.
    Ebrahimian TG; Tamarat R; Clergue M; Duriez M; Levy BI; Silvestre JS
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):65-70. PubMed ID: 15528473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephroprotection in Zucker diabetic fatty rats by vasopeptidase inhibition is partly bradykinin B2 receptor dependent.
    Schäfer S; Schmidts HL; Bleich M; Busch AE; Linz W
    Br J Pharmacol; 2004 Sep; 143(1):27-32. PubMed ID: 15289289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin converting enzyme inhibitor suppresses glomerular transforming growth factor beta receptor expression in experimental diabetes in rats.
    Hill C; Logan A; Smith C; Grønbaek H; Flyvbjerg A
    Diabetologia; 2001 Apr; 44(4):495-500. PubMed ID: 11357481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
    Vora JP; Oyama TT; Thompson MM; Anderson S
    Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphometric detection of incipient glomerular lesions in diabetic nephropathy in rats. Protective effects of ACE inhibition.
    Sassy-Prigent C; Heudes D; Jouquey S; Auberval D; Belair MF; Michel O; Hamon G; Bariety J; Bruneval P
    Lab Invest; 1995 Jul; 73(1):64-71. PubMed ID: 7603042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethyl pyruvate ameliorates albuminuria and glomerular injury in the animal model of diabetic nephropathy.
    Ju KD; Shin EK; Cho EJ; Yoon HB; Kim HS; Kim H; Yang J; Hwang YH; Ahn C; Oh KH
    Am J Physiol Renal Physiol; 2012 Mar; 302(5):F606-13. PubMed ID: 22129969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
    Nakamura T; Obata J; Kimura H; Ohno S; Yoshida Y; Kawachi H; Shimizu F
    Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute renal hemodynamic effects of ACE inhibition in diabetic hyperfiltration: role of kinins.
    Komers R; Cooper ME
    Am J Physiol; 1995 Apr; 268(4 Pt 2):F588-94. PubMed ID: 7733315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.